Last reviewed · How we verify
NCT04421651
Dance Movement Therapy in the Treatment of Depressed Patients: A Randomised Controlled Trial
NA trial testing Dance Movement Therapy group in Depression in 109 participants. Completed in 31 December 2019.
1 October 2018
Quick facts
| Lead sponsor | University of Jyvaskyla |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 109 |
| Start date | 1 January 2017 |
| Primary completion | 1 October 2018 |
| Estimated completion | 31 December 2019 |
Drugs / interventions tested
- Dance Movement Therapy group
Conditions studied
- Depression — all drugs for Depression →
Sponsor
University of Jyvaskyla
Who can join
Adults 18 to 65, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This multi-centre research investigates the effects of dance movement therapy (DMT) on participants diagnosed with depression. In total, 109 persons participated in the study in various locations in Finland. All participants received treatment as usual (TAU). They were randomised into DMT + TAU (n = 52) or TAU-only (n = 57). The participants in the DMT + TAU group were offered 20 DMT sessions twice a week for 10 weeks in addition to standard care. The measurement points included pre-treatment measurement at the baseline and post-treatment measurement at the end of the intervention, which was 10 weeks after the pre-treatment measurement. The follow-up measurement was 3 months after the post-treatment measurement. The effects of the intervention were assessed with a clinical measure of depression (BDI-I) and with indicators of physical and psychological distress (CORE-OM and SCL-90). The participants in the treatment group (DMT+TAU) were compared to the participants in the control group who received TAU-only.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Effects of Dance Movement Therapy in the Treatment of Depression: A Multicenter, Randomized Controlled Trial in Finland.
Hyvönen K, Pylvänäinen P, Muotka J, Lappalainen R. · · 2020 · cited 16× · PMID 32903394 · DOI 10.3389/fpsyg.2020.01687
Verify or expand the search:
- PubMed search for NCT04421651
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Other University of Jyvaskyla trials
Trials by the same sponsor.
- NCT07500922 — Menopause Effects on Cortico-reticular Functioning · NA · not yet recruiting
- NCT07406412 — Hormonal Regulation of Cardiometabolic Health Study · not yet recruiting
- NCT06573086 — Resistance Training, Detraining, and Retraining Study 2024 (TraDeRe2024) · NA · recruiting
- NCT05874986 — Why do People Respond Differently to Resistance Training? · NA · completed
- NCT05553769 — Resistance Training, Detraining, and Retraining Study 2022 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04421651 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Jyvaskyla
- Last refreshed: 9 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04421651.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing